270 related articles for article (PubMed ID: 26897084)
21. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.
Juárez-Verdayes MA; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):53-62. PubMed ID: 22890731
[TBL] [Abstract][Full Text] [Related]
22. A solid-phase approach for the synthesis of muramyl dipeptide conjugates for detection of NOD2.
Kekessie I; Goncharov T; Kőműves LG; Vucic D; Song A
Bioorg Chem; 2021 Nov; 116():105360. PubMed ID: 34562676
[TBL] [Abstract][Full Text] [Related]
23. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
Coulombe F; Divangahi M; Veyrier F; de Léséleuc L; Gleason JL; Yang Y; Kelliher MA; Pandey AK; Sassetti CM; Reed MB; Behr MA
J Exp Med; 2009 Aug; 206(8):1709-16. PubMed ID: 19581406
[TBL] [Abstract][Full Text] [Related]
24. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.
Kamboj A; Patil MT; Petrovsky N; Salunke DB
Eur J Med Chem; 2024 May; 271():116439. PubMed ID: 38691886
[TBL] [Abstract][Full Text] [Related]
26. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.
Wu J; Zhang Y; Xin Z; Wu X
Mol Immunol; 2015 Apr; 64(2):235-43. PubMed ID: 25549945
[TBL] [Abstract][Full Text] [Related]
27. Functional expression of NOD2 in freshly isolated human peripheral blood γδ T cells.
Marischen L; Wesch D; Oberg HH; Rosenstiel P; Trad A; Shomali M; Grötzinger J; Janssen O; Tchikov V; Schütze S; Kabelitz D
Scand J Immunol; 2011 Aug; 74(2):126-34. PubMed ID: 21410503
[TBL] [Abstract][Full Text] [Related]
28. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
29. Membrane targeting enhances muramyl dipeptide binding to NOD2 and Arf6-GTPase in mammalian cells.
Hespen CW; Zhao X; Hang HC
Chem Commun (Camb); 2022 Jun; 58(46):6598-6601. PubMed ID: 35584401
[TBL] [Abstract][Full Text] [Related]
30. Muramyl dipeptide mediated activation of human bronchial epithelial cells interacting with basophils: a novel mechanism of airway inflammation.
Qiu HN; Wong CK; Chu IM; Hu S; Lam CW
Clin Exp Immunol; 2013 Apr; 172(1):81-94. PubMed ID: 23480188
[TBL] [Abstract][Full Text] [Related]
31. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
32. Lipophilic Muramyl Dipeptide-Antigen Conjugates as Immunostimulating Agents.
Willems MM; Zom GG; Meeuwenoord N; Khan S; Ossendorp F; Overkleeft HS; van der Marel GA; Filippov DV; Codée JD
ChemMedChem; 2016 Jan; 11(2):190-8. PubMed ID: 26059481
[TBL] [Abstract][Full Text] [Related]
33. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.
Stafford CA; Gassauer AM; de Oliveira Mann CC; Tanzer MC; Fessler E; Wefers B; Nagl D; Kuut G; Sulek K; Vasilopoulou C; Schwojer SJ; Wiest A; Pfautsch MK; Wurst W; Yabal M; Fröhlich T; Mann M; Gisch N; Jae LT; Hornung V
Nature; 2022 Sep; 609(7927):590-596. PubMed ID: 36002575
[TBL] [Abstract][Full Text] [Related]
35. Freund's adjuvant, NOD2 and mycobacteria.
Behr MA; Divangahi M
Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
[TBL] [Abstract][Full Text] [Related]
36. Designed leucine-rich repeat proteins bind two muramyl dipeptide ligands.
Kim CS; Brown AM; Grove TZ; Etzkorn FA
Protein Sci; 2021 Apr; 30(4):804-817. PubMed ID: 33512005
[TBL] [Abstract][Full Text] [Related]
37. The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment.
Grimes CL; Ariyananda Lde Z; Melnyk JE; O'Shea EK
J Am Chem Soc; 2012 Aug; 134(33):13535-7. PubMed ID: 22857257
[TBL] [Abstract][Full Text] [Related]
38. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2.
Marina-García N; Franchi L; Kim YG; Miller D; McDonald C; Boons GJ; Núñez G
J Immunol; 2008 Mar; 180(6):4050-7. PubMed ID: 18322214
[TBL] [Abstract][Full Text] [Related]
39. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2.
Park OJ; Kim J; Yang J; Yun CH; Han SH
J Bone Miner Res; 2017 Jul; 32(7):1455-1468. PubMed ID: 28337794
[TBL] [Abstract][Full Text] [Related]
40. Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components.
Lee KH; Biswas A; Liu YJ; Kobayashi KS
J Biol Chem; 2012 Nov; 287(47):39800-11. PubMed ID: 23019338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
